Literature DB >> 10212891

Artemisinin antimalarials: mechanisms of action and resistance.

S R Meshnick1.   

Abstract

Artemisinin derivatives are an important new class of antimalarial agents. These compounds contain endoperoxide bridges which are essential for antimalarial activity. Artemisinin is believed to act via a two-step mechanism. Artemisinin is first activated by intraparasitic heme-iron which catalyzes the cleavage of this endoperoxide. A resulting free radical intermediate may then kill the parasite by alkylating and poisoning one or more essential malarial protein(s). No clinically relevant artemisinin-resistant human malaria has yet been reported. However, an artemisinin-resistant strain of murine malaria has been developed and may offer clues to the kinds of resistance that may someday develop in human malarias.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10212891

Source DB:  PubMed          Journal:  Med Trop (Mars)        ISSN: 0025-682X


  14 in total

1.  Molecular cloning and characterization of peroxiredoxin from Toxoplasma gondii.

Authors:  E S Son; K J Song; J C Shin; H W Nam
Journal:  Korean J Parasitol       Date:  2001-06       Impact factor: 1.341

2.  Recent highlights in anti-protozoan drug development and resistance research.

Authors:  Frederick S Buckner; Norman C Waters; Vicky M Avery
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2012-06-12       Impact factor: 4.077

3.  Two isoforms of a divalent metal transporter (DMT1) in Schistosoma mansoni suggest a surface-associated pathway for iron absorption in schistosomes.

Authors:  Danielle J Smyth; Amber Glanfield; Donald P McManus; Elke Hacker; David Blair; Greg J Anderson; Malcolm K Jones
Journal:  J Biol Chem       Date:  2005-11-02       Impact factor: 5.157

4.  Artemisinin resistance in Plasmodium falciparum: A process linked to dormancy?

Authors:  Qin Cheng; Dennis E Kyle; Michelle L Gatton
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2012-01-27       Impact factor: 4.077

Review 5.  The contribution of clinical pharmacology to antimalarial drug discovery and development.

Authors:  Peter Winstanley
Journal:  Br J Clin Pharmacol       Date:  2003-05       Impact factor: 4.335

6.  Artemisinin-resistant mutants of Toxoplasma gondii have altered calcium homeostasis.

Authors:  Kisaburo Nagamune; Silvia N J Moreno; L David Sibley
Journal:  Antimicrob Agents Chemother       Date:  2007-08-13       Impact factor: 5.191

7.  New perspectives on chinese herbal medicine (zhong-yao) research and development.

Authors:  Si-Yuan Pan; Si-Bao Chen; Hong-Guang Dong; Zhi-Ling Yu; Ji-Cui Dong; Zhi-Xian Long; Wang-Fun Fong; Yi-Fan Han; Kam-Ming Ko
Journal:  Evid Based Complement Alternat Med       Date:  2011-03-10       Impact factor: 2.629

8.  In Vivo Efficacy and Parasite Clearance of Artesunate + Sulfadoxine-Pyrimethamine Versus Artemether-Lumefantrine in Mali.

Authors:  Karamoko Niaré; Antoine Dara; Issaka Sagara; Mahamadou S Sissoko; Cheick Oumar Guindo; Nana H Cissé; Cheick Oumar Coulibaly; Pascal Ringwald; Françoise Benoit-Vical; Antoine Berry; Abdoulaye A Djimdé; Ogobara K Doumbo
Journal:  Am J Trop Med Hyg       Date:  2016-01-25       Impact factor: 2.345

9.  Ferronostics: Measuring Tumoral Ferrous Iron with PET to Predict Sensitivity to Iron-Targeted Cancer Therapies.

Authors:  Ning Zhao; Yangjie Huang; Yung-Hua Wang; Ryan K Muir; Ying-Chu Chen; Junnian Wei; Nima Hooshdaran; Pavithra Viswanath; Youngho Seo; Davide Ruggero; Adam R Renslo; Michael J Evans
Journal:  J Nucl Med       Date:  2020-11-27       Impact factor: 10.057

10.  Role of transferrin receptor and the ABC transporters ABCB6 and ABCB7 for resistance and differentiation of tumor cells towards artesunate.

Authors:  Gerhard Kelter; Daniel Steinbach; Venkata Badireenath Konkimalla; Tsuyoshi Tahara; Shigeru Taketani; Heinz-Herbert Fiebig; Thomas Efferth
Journal:  PLoS One       Date:  2007-08-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.